MedFluid at WSAVA Congress 2026: See the NAST System Live in Warsaw!

MedFluid is thrilled to announce our upcoming participation in the WSAVA Congress 2026 in Warsaw, Poland!

This October, we are proud to showcase our latest Made-in-Taiwan veterinary innovation to professionals worldwide: NAST, the original in-clinic antibiotic susceptibility test.Historically, veterinary practices have had to wait 3 to 7 days for external laboratory antibiotic test results. Powered by MedFluid’s proprietary rapid microfluidic testing technology, the NAST system empowers clinics to obtain highly precise data in a fraction of the time, ensuring patients receive the most effective treatment right when they need it.

Core Advantages of the NAST System:

  • ⏱️ 6-Hour Results (not 3-7 days) Dramatically reduce the waiting period. By delivering results in just 6 hours, veterinarians can confidently adjust treatment plans based on scientific data within the very same shift.

  • 📊 True MIC Values (not just S / I / R) Move beyond broad Susceptible / Intermediate / Resistant classifications. NAST provides true Minimum Inhibitory Concentration (MIC) values, enabling precise and targeted antimicrobial stewardship.

  • ⚙️ Cartridge-Based (load and walk away) Designed for seamless integration into your busy clinic. Simply load the sample cartridge and walk away—allowing your staff to focus on patient care while the system handles the testing.

【Event Details】

  • Date: 13–15 October 2026

  • Location: EXPO XXI Convention Center, Warsaw, Poland

  • MedFluid Booth: #89

Whether you are a veterinary professional looking to upgrade your in-house diagnostics or a distributor seeking innovative partnerships, the MedFluid team looks forward to welcoming you to Booth #89!

For more details on NAST and our underlying technology, visit medfluid.com.tw.

© Copyright – MedFluid | design by Morcept